Skip to main content
Erschienen in: Journal of Clinical Immunology 2/2022

20.11.2021 | Original Article

Immunological Evaluation of Patients Affected with Jacobsen Syndrome Reveals Profound Not Age-Related Lymphocyte Alterations

verfasst von: Manuela Baronio, Francesco Saettini, Luisa Gazzurelli, Stefano Rossi, Antonio Marzollo, Silvia Ricci, Daniele Zama, Boaz Palterer, Canessa Clementina, Lodi Lorenzo, Marco Chiarini, Alessandra Sottini, Luisa Imberti, Chiara Gorio, Linda Rossini, Raffaele Badolato, Alessandro Plebani, Daniele Moratto, Vassilios Lougaris

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Jacobsen syndrome (JS) is a rare form of genetic disorder that was recently classified as a syndromic immunodeficiency. Available detailed immunological data from JS patients are limited.

Methods

Clinical and immunological presentation of twelve pediatric patients with JS by means of revision of clinical records, flow cytometry, real-time PCR, and lymphocyte functional testing were collected.

Results

Recurrent infections were registered in 6/12 patients (50%), while bleeding episodes in 2/12 (16.7%). White blood cell and absolute lymphocyte counts were reduced in 8/12 (66.7%) and 7/12 (58.3%) patients, respectively. Absolute numbers of CD3+ and CD4+ T cells were reduced in 8/12 (66.7%) and 7/12 (58.3%), respectively. Of note, recent thymic emigrants (RTE) were reduced in all tested patients (9/9), with T-cell receptor excision circle analysis (TRECs) showing a similar trend in 8/9 patients; naïve CD4+ T cells were low only in 5/11 patients (45.4%). Interestingly, B-cell counts, IgM memory B cells, and IgM serum levels were reduced in 10/12 (83.3%) patients. Natural killer (NK) cell counts were mostly normal but the percentages of CD16+CD56low/− cells were expanded in 7/7 patients tested. The observed immunological alterations did not correlate with patients’ age. Finally, responses to proliferative stimuli were normal at presentation for all patients, although they may deteriorate over time.

Conclusions

Our data suggest that patients affected with JS may display important numeric and maturational alterations in the T-, B-, and NK-cell compartments. These findings suggest that JS patients should be regularly monitored from an immunological point of view.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat Penny LA, Dell’Aquila M, Jones MC, Bergoffen J, Cunniff C, Fryns JP, et al. Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet. 1995;56(3):676–83.PubMedPubMedCentral Penny LA, Dell’Aquila M, Jones MC, Bergoffen J, Cunniff C, Fryns JP, et al. Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet. 1995;56(3):676–83.PubMedPubMedCentral
5.
Zurück zum Zitat Tootleman E, Malamut B, Akshoomoff N, Mattson SN, Hoffman HM, Jones MC, et al. Partial Jacobsen syndrome phenotype in a patient with a de novo frameshift mutation in the ETS1 transcription factor. Cold Spring Harb Mol Case Stud. 2019;5(3):1–9. https://doi.org/10.1101/mcs.a004010.CrossRef Tootleman E, Malamut B, Akshoomoff N, Mattson SN, Hoffman HM, Jones MC, et al. Partial Jacobsen syndrome phenotype in a patient with a de novo frameshift mutation in the ETS1 transcription factor. Cold Spring Harb Mol Case Stud. 2019;5(3):1–9. https://​doi.​org/​10.​1101/​mcs.​a004010.CrossRef
Metadaten
Titel
Immunological Evaluation of Patients Affected with Jacobsen Syndrome Reveals Profound Not Age-Related Lymphocyte Alterations
verfasst von
Manuela Baronio
Francesco Saettini
Luisa Gazzurelli
Stefano Rossi
Antonio Marzollo
Silvia Ricci
Daniele Zama
Boaz Palterer
Canessa Clementina
Lodi Lorenzo
Marco Chiarini
Alessandra Sottini
Luisa Imberti
Chiara Gorio
Linda Rossini
Raffaele Badolato
Alessandro Plebani
Daniele Moratto
Vassilios Lougaris
Publikationsdatum
20.11.2021
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2022
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-021-01169-2

Weitere Artikel der Ausgabe 2/2022

Journal of Clinical Immunology 2/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.